Literature DB >> 4825247

Plague immunization. IV. Clinical reactions and serologic response to inoculations of Haffkine and freeze-dried plague vaccine.

K F Meyer, G Smith, L E Foster, J D Marshall, D C Cavanaugh.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4825247     DOI： 10.1093/infdis/129.supplement_1.s30

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

1.  Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plague.

Authors:  Devender Kumar; Girish Kirimanjeswara; Dennis W Metzger
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

2.  Milestones in progression of primary pneumonic plague in cynomolgus macaques.

Authors:  Frederick Koster; David S Perlin; Steven Park; Trevor Brasel; Andrew Gigliotti; Edward Barr; Leslie Myers; Robert C Layton; Robert Sherwood; C R Lyons
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

3.  LcrV plague vaccine with altered immunomodulatory properties.

Authors:  Katie A Overheim; R William Depaolo; Kristin L Debord; Elizabeth M Morrin; Debra M Anderson; Nathaniel M Green; Robert R Brubaker; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.

Authors:  Lauriane E Quenee; Nancy A Ciletti; Derek Elli; Timothy M Hermanas; Olaf Schneewind
Journal:  Vaccine       Date:  2011-07-16       Impact factor: 3.641

5.  Human immune response to a plague vaccine comprising recombinant F1 and V antigens.

Authors:  E D Williamson; H C Flick-Smith; C Lebutt; C A Rowland; S M Jones; E L Waters; R J Gwyther; J Miller; P J Packer; M Irving
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Measuring the efficacy of vaccination in affording protection against plague.

Authors:  J E Williams; D C Cavanaugh
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

7.  Yersinia pestis caf1 variants and the limits of plague vaccine protection.

Authors:  Lauriane E Quenee; Claire A Cornelius; Nancy A Ciletti; Derek Elli; Olaf Schneewind
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

8.  Clinical and pathologic features of cynomolgus macaques (Macaca fascicularis) infected with aerosolized Yersinia pestis.

Authors:  Roger Van Andel; Robert Sherwood; Chris Gennings; C Richard Lyons; Julie Hutt; Andrew Gigliotti; Ed Barr
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.